BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 17693408)

  • 1. Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress.
    Abad M; Menéndez C; Füchtbauer A; Serrano M; Füchtbauer EM; Palmero I
    J Biol Chem; 2007 Oct; 282(42):31060-7. PubMed ID: 17693408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ING1 and ING2: multifaceted tumor suppressor genes.
    Guérillon C; Larrieu D; Pedeux R
    Cell Mol Life Sci; 2013 Oct; 70(20):3753-72. PubMed ID: 23412501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG.
    Takahashi M; Seki N; Ozaki T; Kato M; Kuno T; Nakagawa T; Watanabe K; Miyazaki K; Ohira M; Hayashi S; Hosoda M; Tokita H; Mizuguchi H; Hayakawa T; Todo S; Nakagawara A
    Cancer Res; 2002 Apr; 62(8):2203-9. PubMed ID: 11956069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression.
    Gong W; Russell M; Suzuki K; Riabowol K
    Mol Cell Biol; 2006 Apr; 26(8):2947-54. PubMed ID: 16581770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated expression of lamin B receptor increases cell proliferation and suppresses genomic instability: implications for cellular immortalization.
    En A; Takemoto K; Yamakami Y; Nakabayashi K; Fujii M
    FEBS J; 2024 May; 291(10):2155-2171. PubMed ID: 38462947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the tumour suppressor p33 ING1b in human neoplasia.
    Nouman GS; Anderson JJ; Lunec J; Angus B
    J Clin Pathol; 2003 Jul; 56(7):491-6. PubMed ID: 12835293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic retargeting of p53 and CTCF is associated with transcriptional changes during oncogenic HRas-induced transformation.
    Schwartz M; Portugez AS; Attia BZ; Tannenbaum M; Cohen L; Loza O; Chase E; Turman Y; Kaplan T; Salah Z; Hakim O
    Commun Biol; 2020 Nov; 3(1):696. PubMed ID: 33239721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNAJB9 Inhibits p53-Dependent Oncogene-Induced Senescence and Induces Cell Transformation.
    Lee HJ; Jung YJ; Lee S; Kim JI; Han JA
    Mol Cells; 2020 Apr; 43(4):397-407. PubMed ID: 32264658
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncogenic K-Ras
    Ito M; Tanuma N; Kotani Y; Murai K; Kondo A; Sumiyoshi M; Shima H; Matsuda S; Watanabe T
    FEBS Open Bio; 2024 Apr; 14(4):545-554. PubMed ID: 38318686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splicing regulator SC35 is essential for genomic stability and cell proliferation during mammalian organogenesis.
    Xiao R; Sun Y; Ding JH; Lin S; Rose DW; Rosenfeld MG; Fu XD; Li X
    Mol Cell Biol; 2007 Aug; 27(15):5393-402. PubMed ID: 17526736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formation.
    Wilson CH; Crombie C; van der Weyden L; Poulogiannis G; Rust AG; Pardo M; Gracia T; Yu L; Choudhary J; Poulin GB; McIntyre RE; Winton DJ; March HN; Arends MJ; Fraser AG; Adams DJ
    EMBO J; 2012 May; 31(11):2486-97. PubMed ID: 22510880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond SAHF: An integrative view of chromatin compartmentalization during senescence.
    Olan I; Handa T; Narita M
    Curr Opin Cell Biol; 2023 Aug; 83():102206. PubMed ID: 37451177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress.
    Abad M; Menéndez C; Füchtbauer A; Serrano M; Füchtbauer EM; Palmero I
    J Biol Chem; 2021; 296():100406. PubMed ID: 33837733
    [No Abstract]   [Full Text] [Related]  

  • 14. ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer.
    Melekhova A; Baniahmad A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ING Proteins: Tumour Suppressors or Oncoproteins.
    Jacquet K; Binda O
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33925563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered endocytosis in cellular senescence.
    Shin EY; Soung NK; Schwartz MA; Kim EG
    Ageing Res Rev; 2021 Jul; 68():101332. PubMed ID: 33753287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence and Apoptosis: Architects of Mammalian Development.
    Wanner E; Thoppil H; Riabowol K
    Front Cell Dev Biol; 2020; 8():620089. PubMed ID: 33537310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the minimal peptide sequence of the ING1b tumour suppressor capable of efficiently inducing apoptosis.
    Boyko A; Riabowol K
    Cell Death Discov; 2015; 1():15048. PubMed ID: 27551477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INGs are potential drug targets for cancer.
    Zhang R; Jin J; Shi J; Hou Y
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):189-197. PubMed ID: 27544390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.
    Ceruti JM; Ogara MF; Menéndez C; Palmero I; Cánepa ET
    Mol Cell Biochem; 2013 Jun; 378(1-2):117-26. PubMed ID: 23459830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.